Engineering Particles for Therapeutic Delivery: Prospects and Challenges
Source abstract
Abstract
Nanoengineered particles that can facilitate drug formulation and passively target tumors have reached the clinic in recent years. These early successes have driven a new wave of significant innovation in the generation of advanced particles. Recent developments in enabling technologies and chemistries have led to control over key particle properties, including surface functionality, size, shape, and rigidity. Combining these advances with the rapid developments in the discovery of many disease-related characteristics now offers new opportunities for improving particle specificity for targeted therapy. In this Perspective, we summarize recent progress in particle-based therapeutic delivery and discuss important concepts in particle design and biological barriers for developing the next generation of particles.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · RNA Interference and Gene Delivery · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemical and Biomolecular Engineering, The University of Melbourne, Victoria 3010, Australia
References (32)
Show source-provided references
1. Moghimi S. M. · ACS Nano · 2011 · 5 · 845410.1021/nn2038252 ↗
2. Kamaly N. · Chem. Soc. Rev. · 2012 · 41 · 297110.1039/c2cs15344k ↗
3. Wang A. Z. · Annu. Rev. Med. · 2012 · 63 · 18510.1146/annurev-med-040210-162544 ↗
4. Jain R. K. · Nat. Rev. Clin. Oncol. · 2010 · 11 · 65310.1038/nrclinonc.2010.139 ↗
5. Weiner L. M. · Nat. Rev. Immunol. · 2010 · 10 · 31710.1038/nri2744 ↗
6. Kole R. · Nat. Rev. Drug Discovery · 2012 · 11 · 12510.1038/nrd3625 ↗
7. Blanco E. · Cancer Sci. · 2011 · 102 · 124710.1111/j.1349-7006.2011.01941.x ↗
8. Low P. S. · Acc. Chem. Res. · 2008 · 41 · 12010.1021/ar7000815 ↗
9. Lee S.-M. · J. Am. Chem. Soc. · 2009 · 131 · 931110.1021/ja9017336 ↗
10. Davis M. E. · Nature · 2010 · 464 · 106710.1038/nature08956 ↗
11. Drummond D. C. · J. Controlled Release · 2010 · 141 · 1310.1016/j.jconrel.2009.08.006 ↗
12. Shuvaev V. V. · ACS Nano · 2011 · 5 · 699110.1021/nn2015453 ↗
13. Scott A. M. · Proc. Natl. Acad. Sci. U.S.A. · 2007 · 104 · 407110.1073/pnas.0611693104 ↗
14. Chong G. · Clin. Cancer Res. · 2005 · 11 · 481810.1158/1078-0432.CCR-04-2330 ↗
15. Kamphuis M. M. J. · J. Am. Chem. Soc. · 2010 · 132 · 1588110.1021/ja106405c ↗
16. 10.1073/pnas.112162310910.1073/pnas.1121623109 ↗
17. Doherty G. J. · Annu. Rev. Biochem. · 2009 · 78 · 85710.1146/annurev.biochem.78.081307.110540 ↗
18. Best J. P. · Adv. Healthcare Mater. · 2012 · 1 · 3510.1002/adhm.201100012 ↗
19. Rejman J. · Biochem. J. · 2004 · 377 · 15910.1042/bj20031253 ↗
20. Jiang W. · Nat. Nanotechnol. · 2008 · 3 · 14510.1038/nnano.2008.30 ↗
21. Gratton S. E. A. · Proc. Natl. Acad. Sci. U.S.A. · 2008 · 105 · 1161310.1073/pnas.0801763105 ↗
22. Champion J. A. · Proc. Natl. Acad. Sci. U.S.A. · 2006 · 103 · 493010.1073/pnas.0600997103 ↗
23. Geng Y. · Nat. Nanotechnol. · 2007 · 2 · 24910.1038/nnano.2007.70 ↗
24. Banquy X. · Soft Matter · 2009 · 5 · 398410.1039/b821583a ↗
25. Dausend J. · Macromol. Biosci. · 2008 · 8 · 113510.1002/mabi.200800123 ↗
26. El-Sayed A. · J. Biol. Chem. · 2008 · 283 · 2340510.1074/jbc.M709387200 ↗
27. Khalil I. A. · J. Biol. Chem. · 2006 · 281 · 354410.1074/jbc.M503202200 ↗
28. Fujiwara T. · Int. J. Pharm. · 2010 · 386 · 12210.1016/j.ijpharm.2009.11.005 ↗
29. Pack D. W. · Nat. Rev. Drug Discovery · 2005 · 4 · 58110.1038/nrd1775 ↗
30. Hu Y. · Nano Lett. · 2007 · 7 · 305610.1021/nl071542i ↗
31. Lomas H. · Adv. Mater. · 2007 · 19 · 423810.1002/adma.200700941 ↗
32. Wagstaff K. M. · Biochem. J. · 2007 · 406 · 18510.1042/BJ20070505 ↗